Structure and function of heparan sulphate proteoglycansJ. T. Gallagher, William P. Steward|Biochemical Journal|1986Cited by 486
Gemcitabine and capecitabine with or without telomerase peptide vaccine GV1001 in patients with locally advanced or metastatic pancreatic cancer (TeloVac): an open-label, randomised, phase 3 trialGary Middleton, John P. Neoptolemos, David Cunningham et al.|The Lancet Oncology|2014Cited by 374
Phase III trial of 5-fluorouracil and leucovorin plus either 3H1 anti-idiotype monoclonal antibody or placebo in patients with advanced colorectal cancerGeoff Chong, J Carmichael, Anish Bhatnagar et al.|Annals of Oncology|2005Cited by 32
A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of a three-weekly cycle in combination with carboplatin given on day 1 alone in patients with advanced solid tumoursAlastair Greystoke, William P. Steward, Sarah P. Blagden et al.|Annals of Oncology|2006Cited by 24
Title Page / ContentsS.W.J. Lamberts, David Nott, Anna Maria Baldelli et al.|Chemotherapy|2001Cited by 0